Cohort Study of Prospective Validation of Predictive Factors and Biological Imaging of Response to Bevacizumab and Paclitaxel in Patients With Metastatic Breast Cancer
Status: COMPLETED
Study type: OBSERVATIONAL
Conditions: Metastatic|Breast Cancer
Interventions: DRUG: Bevacizumab|DRUG: paclitaxel
Sponsor: UNICANCER